All Bayer articles
-
OpinionGetting into the weeds of the glyphosate debate
Assessments of the risk posed by the controversial herbicide depend on how the evidence is weighed
-
-
-
BusinessThree US juries side with cancer victims over Bayer on Roundup
Bayer unit Monsanto has lost its ‘winning streak’ of nine defence verdicts, and the company plans to appeal
-
OpinionWho knew what? And when?
Finding the line between commercially sensitive information and public and environmental protection
-
BusinessAnti-drift additives may volatilise alongside herbicides, causing pollution
Research suggests amine salts could be entering atmosphere, but manufacturers say lab model is unrealistic
-
BusinessMonsanto agrees $12 million settlement for Hawaii pesticide violations
Bayer-owned firm admits charges relating to use and storage of pesticides on its research farms
-
BusinessBees face a barrage of chemical and environmental burdens
Better understanding of the combined effects of multiple stress factors could help reduce pollinator decline
-
BusinessAppeals court cuts damages further in glyphosate cancer case
Judgment retains verdict that Bayer-Monsanto’s herbicide caused US man’s cancer
-
BusinessBayer commits over $10bn to resolve legacy Monsanto lawsuits
Agreement settles about 75% of Roundup-related cases and resolves PCB and dicamba litigation
-
BusinessFrance to ban 36 glyphosate products by end of 2020
Move follows similar bans in several European states, with safety agency citing ‘absence of scientific data ruling out genotoxic risks’
-
BusinessUS judges slash damages in glyphosate cancer lawsuits
While upholding rulings linking the herbicide to cancer, judges have cut Bayer-Monsanto’s fines from billions to tens of millions of dollars
-
BusinessAustria becomes first EU country to fully outlaw glyphosate
A ban of the controversial herbicide from 2020 has been approved by the Austrian government
-
OpinionIs Bayer regretting its Monsanto takeover?
Large damages in Roundup litigation have got investors questioning the move
-
BusinessJury awards $2bn damages in US glyphosate trial
Bayer vows to appeal third defeat over Monsanto’s Roundup weedkiller, while experts suggest damages will likely be reduced
-
OpinionShow me the data
Making industrial safety research more transparent benefits both companies and consumers
-
NewsWhy jury verdicts get overruled in US industry cancer trials
Judges often end up intervening post-trial in complex cases with conflicting scientific evidence
-
BusinessChemicals industry roundup 2018
Industry growth remains strong despite tariff disputes, political uncertainty and supply chain challenges
-
BusinessBayer to cut 12000 jobs
As it integrates Monsanto businesses, Bayer will eliminate around 10% of its global workforce
-
BusinessBayer–Monsanto merger momentum
US antitrust regulators approve Bayer’s $66bn takeover of Monsanto, conditional on the company offloading $9bn in assets